Newsroom
Sorted by: Latest
-
TMV Logistics Launches $200M Maritime and Logistics Fund Anchored by American Bureau of Shipping (ABS) and Prologis Ventures
NEW YORK--(BUSINESS WIRE)--TMV today announced the launch of TMV Logistics, LP, a $200M venture fund dedicated to maritime and logistics innovation and safety. The fund is anchored by strategic commitments from American Bureau of Shipping (ABS), the global leader in classification and technical advisory services and Prologis Ventures, the strategic investment arm of Prologis (NYSE: PLD), the world's leading logistics real estate company. TMV Logistics will back pre-seed through Series A compani...
-
Omdia: European Smartphone Market Grows 2% in 1Q26 as Prices Hit Record High
LONDON--(BUSINESS WIRE)--Omdia’s latest research reveals that Europe’s smartphone market (excluding Russia) grew 2% to 33.0 million units in 1Q26, showing resilience amid growing supply-side costs and increasing risks of availability bottlenecks. Healthy end-user demand alongside channel frontloading helped boost the market. Key vendor highlights from 1Q26 include: Samsung was Europe’s largest vendor as it grew 3% to 12.6 million units. Effective discounting of the Galaxy A16 4G helped Samsung...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Cloud Computing UCITS ETF 25.05.2026 CPQ IE00BFD2H405 7,175,002.00 USD 400,952,335.49 55.882 ...
-
BeOne Medicines to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
SAN CARLOS, Calif.--(BUSINESS WIRE)--BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will participate in the Goldman Sachs 47th Annual Global Healthcare Conference on June 8, 2026, with a fireside chat at 10:00 a.m. EDT. The live webcast of this event can be accessed from the investors section of the Company’s website at https://ir.beonemedicines.com. An archived webcast will be available on the Company’s website. About BeOne BeOne Med...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Dow Jones Internet UCITS ETF 25.05.2026 FDNU IE00BG0SSC32 1,225,002.00 USD 46,302,938.81 37.798 ...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Nasdaq Cybersecurity UCITS ETF 25.05.2026 NQCYBREN IE00BF16M727 27,308,218.00 USD 1,422,042,271.26 52.074 ...
-
BY THE POWER OF GRAYSKULL AND KRISPY KREME®: We’re Entering a New Era of Doughnut Deliciousness with the All-New Masters of the Universe Collection
CHARLOTTE, N.C.--(BUSINESS WIRE)--He-Man has faced countless villains, and now he’s teaming up with Krispy Kreme® to usher in a new era of doughnut deliciousness, defending flavor, fun and epic sweet cravings everywhere. Beginning Tuesday, May 26, at participating shops across the U.S., Krispy Kreme® in collaboration with Mattel and Amazon MGM Studios is unleashing the Masters of the Universe® Collection – three all-new doughnuts available for a limited time and a custom dozen box inspired by M...
-
GlobalPlatform Launches Pavona: The First Open Silicon Distribution with Production-Grade Post-Quantum Cryptography
REDWOOD CITY, Calif.--(BUSINESS WIRE)--GlobalPlatform Launches Pavona: Open-source trusted silicon ecosystem with Post-Quantum Cryptography. 12 founding members join - with more to follow...
-
Personalis to Highlight Breadth of NeXT Personal® Ultra-Sensitive ctDNA Data at ASCO 2026 Annual Meeting, Including Podium Presentation from TRACERx Consortium
FREMONT, Calif.--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced that six clinical abstracts demonstrating the broad use of its NeXT Personal® test will be presented at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place May 29 to June 2 in Chicago. Highlights include an oral podium presentation from the landmark TRACERx study, which demonstrates the clinical impact of NeXT Personal’s single-d...
-
Natera to Launch Enhanced Panorama™ NIPT, Powered by Novel SNP-Informed Deep Sequencing Technology
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) testing and precision medicine, today announced a major enhancement to its Panorama non-invasive prenatal test (NIPT). Powered by the company’s novel SNP-informed deep sequencing technology, Panorama NIPT is now backed by clinically-validated performance data in samples with low fetal fraction, enabling a no-call rate of 0.5%. Fetal fraction refers to the proportion of placental DNA circulating...